A detailed history of Pinnacle Financial Partners Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Pinnacle Financial Partners Inc holds 730 shares of EW stock, worth $49,464. This represents 0.0% of its overall portfolio holdings.

Number of Shares
730
Previous 1,530 52.29%
Holding current value
$49,464
Previous $141,000 65.96%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$59.7 - $93.78 $47,760 - $75,024
-800 Reduced 52.29%
730 $48,000
Q2 2024

Aug 06, 2024

SELL
$84.3 - $94.31 $211,593 - $236,718
-2,510 Reduced 62.13%
1,530 $141,000
Q1 2024

Apr 30, 2024

BUY
$72.54 - $95.56 $182,075 - $239,855
2,510 Added 164.05%
4,040 $386,000
Q3 2023

Nov 03, 2023

SELL
$69.28 - $93.38 $177,564 - $239,332
-2,563 Reduced 62.62%
1,530 $105,000
Q2 2023

Aug 07, 2023

BUY
$81.41 - $94.33 $208,653 - $241,767
2,563 Added 167.52%
4,093 $386,000
Q3 2022

Oct 31, 2022

BUY
$82.37 - $107.29 $126,026 - $164,153
1,530 New
1,530 $126,000
Q2 2022

Jul 29, 2022

SELL
$86.5 - $128.27 $37,627 - $55,797
-435 Closed
0 $0
Q4 2021

Feb 01, 2022

SELL
$106.37 - $130.68 $23,401 - $28,749
-220 Reduced 33.59%
435 $56,000
Q3 2021

Oct 26, 2021

BUY
$102.91 - $122.75 $22,640 - $27,005
220 Added 50.57%
655 $74,000
Q2 2021

Jul 21, 2021

BUY
$83.84 - $104.76 $36,470 - $45,570
435 New
435 $45,000
Q1 2019

May 02, 2019

SELL
$47.89 - $64.05 $66,040 - $88,324
-1,379 Closed
0 $0
Q4 2018

Feb 04, 2019

SELL
$46.41 - $56.94 $17,357 - $21,295
-374 Reduced 21.33%
1,379 $211,000
Q3 2018

Oct 31, 2018

BUY
$45.7 - $58.03 $57,262 - $72,711
1,253 Added 250.6%
1,753 $305,000
Q2 2018

Jul 27, 2018

BUY
$42.45 - $51.3 $21,225 - $25,650
500 New
500 $73,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Pinnacle Financial Partners Inc Portfolio

Follow Pinnacle Financial Partners Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Financial Partners Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Financial Partners Inc with notifications on news.